Blood Transfusion Diagnostics Market To Surpass USD 3,813.1 Million By 2028 At A CAGR Of 6.7%
The report analyzes and forecasts the Blood Transfusion Diagnostics Market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2022 to 2030. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global Blood Transfusion Diagnostics Market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the Blood Transfusion Diagnostics Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of Blood Transfusion Diagnostics Market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Download Sample Report Copy From Here:https://www.acumenresearchandconsulting.com/request-sample/2832
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding. Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
Market Players as below:
Some of the major participants in the blood transfusion diagnostics market are Abbott, BAG Healthcare GmbH, Immucor Inc., Danaher, Quotient Limited, Bio-Rad Laboratories, Ortho Clinical Diagnostics, F. Hoffmann-La Roche AG, DiaSorin S.P.A., BIOKIT (Werfen), among others.
The major market segments of Blood Transfusion Diagnostics Market are as below:
Market By Product
- Reagents & Kits
- Instruments
- Others
Market By Application
- Blood Grouping
- Disease Screening
- Serological Disease Screening
- Molecular Disease Screening
Market By End-use
- Hospitals
- Blood Banks
- Diagnostic Laboratories
- Others
Ask Query Here: richard@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com
Table Of Contents:
CHAPTER 1. Industry Overview of Blood Transfusion Diagnostics
1.1. Definition and Scope
1.1.1. Definition of Blood Transfusion Diagnostics
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Blood Transfusion Diagnostics market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Blood Transfusion Diagnostics By Product
1.2.3. Blood Transfusion Diagnostics By Application
1.2.4. Blood Transfusion Diagnostics By End-Use
1.2.5. Blood Transfusion Diagnostics by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Blood Transfusion Diagnostics Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Blood Transfusion Diagnostics Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2019
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019
4.2. R&D Status and Application Source of Blood Transfusion Diagnostics Major Manufacturers in 2019
CHAPTER 5. Blood Transfusion Diagnostics By Product
5.1. Introduction
5.2. Blood Transfusion Diagnostics Revenue By Product
5.2.1. Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast, By Product, 2017-2028
5.2.2. Reagents & Kits
5.2.2.1. Reagents & Kits Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
5.2.3. Instruments
5.2.3.1. Instruments Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
5.2.4. Others
5.2.4.1. Others Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
CHAPTER 6. Blood Transfusion Diagnostics Market Revenue By Application
6.1. Introduction
6.2. Blood Transfusion Diagnostics Revenue (US$ Bn) By Application
6.2.1. Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028
6.2.2. Blood Grouping
6.2.2.1. Blood Grouping Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
6.2.3. Disease Screening
6.2.3.1. Disease Screening Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
6.2.3.1.1. Serological Disease Screening
6.2.3.1.1.1. Serological Disease Screening Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
6.2.3.1.2. Molecular Disease Screening
6.2.3.1.2.1. Molecular Disease Screening Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
CHAPTER 7. Blood Transfusion Diagnostics Market By End-use
7.1. Introduction
7.2. Blood Transfusion Diagnostics Revenue (US$ Bn) By Product
7.2.1. Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028
7.2.2. Hospitals
7.2.2.1. Hospitals Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
7.2.3. Blood Banks
7.2.3.1. Blood Banks Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
7.2.4. Diagnostic Laboratories
7.2.4.1. Diagnostic Laboratories Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
7.2.5. Others
7.2.5.1. Others Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
CHAPTER 8. North America Blood Transfusion Diagnostics Market By Country
8.1. North America Blood Transfusion Diagnostics Overview
8.2. U.S.
8.2.1. U.S. Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028
8.2.2. U.S. Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028
8.2.3. U.S. Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028
8.3. Canada
8.3.1. Canada Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028
8.3.2. Canada Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028
8.3.3. Canada Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028
8.4. North America PEST Analysis
CHAPTER 9. Europe Blood Transfusion Diagnostics Market By Country
9.1. Europe Blood Transfusion Diagnostics Overview
9.2. U.K.
9.2.1. U.K. Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028
9.2.2. U.K. Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028
9.2.3. U.K. Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028
9.3. Germany
9.3.1. Germany Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028
9.3.2. Germany Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028
9.3.3. Germany Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028
9.4. France
9.4.1. France Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028
9.4.2. France Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028
9.4.3. France Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028
9.5. Spain
9.5.1. Spain Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028
9.5.2. Spain Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028
9.5.3. Spain Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028
9.6. Rest of Europe
9.6.1. Rest of Europe Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028
9.6.2. Rest of Europe Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028
9.6.3. Rest of Europe Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Blood Transfusion Diagnostics Market By Country
10.1. Asia Pacific Blood Transfusion Diagnostics Overview
10.2. China
10.2.1. China Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028
10.2.2. China Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028
10.2.3. China Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028
10.3. Japan
10.3.1. Japan Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028
10.3.2. Japan Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028
10.3.3. Japan Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028
10.4. India
10.4.1. India Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028
10.4.2. India Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028
10.4.3. India Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028
10.5. Australia
10.5.1. Australia Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028
10.5.2. Australia Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028
10.5.3. Australia Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028
10.6. South Korea
10.6.1. South Korea Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028
10.6.2. South Korea Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028
10.6.3. South Korea Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028
10.7.2. Rest of Asia-Pacific Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028
10.7.3. Rest of Asia-Pacific Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Blood Transfusion Diagnostics Market By Country
11.1. Latin America Blood Transfusion Diagnostics Overview
11.2. Brazil
11.2.1. Brazil Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028
11.2.2. Brazil Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028
11.2.3. Brazil Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028
11.3. Mexico
11.3.1. Mexico Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028
11.3.2. Mexico Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028
11.3.3. Mexico Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028
11.4. Rest of Latin America
11.4.1. Rest of Latin America Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028
11.4.2. Rest of Latin America Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028
11.4.3. Rest of Latin America Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Blood Transfusion Diagnostics Market By Country
12.1. Middle East & Africa Blood Transfusion Diagnostics Overview
12.2. GCC
12.2.1. GCC Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028
12.2.2. GCC Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028
12.2.3. GCC Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028
12.3. South Africa
12.3.1. South Africa Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028
12.3.2. South Africa Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028
12.3.3. South Africa Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Product, 2017-2028
12.4.2. Rest of Middle East & Africa Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By Application, 2017-2028
12.4.3. Rest of Middle East & Africa Blood Transfusion Diagnostics Revenue (US$ Bn) and Forecast By End-use, 2017-2028
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Blood Transfusion Diagnostics
13.1. Blood Transfusion Diagnostics Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Blood Transfusion Diagnostics market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. COMPANY PROFILE
14.1. Abbott Laboratories
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (US$ Bn), 2020
14.1.3.2. Abbott Laboratories 2020 Blood Transfusion Diagnostics Business Regional Distribution
14.1.4. Product/ Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. BAG Healthcare GmbH
14.3. Immucor Inc.
14.4. Danaher
14.5. Ortho Clinical Diagnostics
14.6. Bio-Rad Laboratories
14.7. F. Hoffmann-La Roche AG
14.8. Quotient Limited
14.9. DiaSorin S.P.A.
14.10. BIOKIT (Werfen)
To Get Premium Report Full Copy in Form of Single user or Multiple user@https://www.acumenresearchandconsulting.com/buy-now/0/2832
About Us:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
